Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial

Solomon Tesfaye, Gordon Sloan, Jennifer Petrie, David White, Mike Bradburn, Steven Julious, Satyan Rajbhandari, Sanjeev Sharma, Gerry Rayman, Ravikanth Gouni, Uazman Alam, Cindy Cooper, Amanda Loban, Katie Sutherland, Rachel Glover, Simon Waterhouse, Emily Turton, Michelle Horspool, Rajiv Gandhi, Deirdre Maguire, Edward B Jude, Syed H Ahmed, Prashanth Vas, Christian Hariman, Claire McDougall, Marion Devers, Vasileios Tsatlidis, Martin Johnson, Andrew S C Rice, Didier Bouhassira, David L Bennett, Dinesh Selvarajah

Open source

DOI: 10.1016/s0140-6736(22)01472-6
Published: 2022-08
Container: The Lancet
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-22-01472-6,
  title = {Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial},
  author = {Solomon Tesfaye and Gordon Sloan and Jennifer Petrie and David White and Mike Bradburn and Steven Julious and Satyan Rajbhandari and Sanjeev Sharma and Gerry Rayman and Ravikanth Gouni and Uazman Alam and Cindy Cooper and Amanda Loban and Katie Sutherland and Rachel Glover and Simon Waterhouse and Emily Turton and Michelle Horspool and Rajiv Gandhi and Deirdre Maguire and Edward B Jude and Syed H Ahmed and Prashanth Vas and Christian Hariman and Claire McDougall and Marion Devers and Vasileios Tsatlidis and Martin Johnson and Andrew S C Rice and Didier Bouhassira and David L Bennett and Dinesh Selvarajah},
  year = {2022},
  journal = {The Lancet},
  doi = {10.1016/s0140-6736(22)01472-6},
  url = {https://doi.org/10.1016/s0140-6736(22)01472-6}
}

RIS

TY  - JOUR
TI  - Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial
AU  - Solomon Tesfaye
AU  - Gordon Sloan
AU  - Jennifer Petrie
AU  - David White
AU  - Mike Bradburn
AU  - Steven Julious
AU  - Satyan Rajbhandari
AU  - Sanjeev Sharma
AU  - Gerry Rayman
AU  - Ravikanth Gouni
AU  - Uazman Alam
AU  - Cindy Cooper
AU  - Amanda Loban
AU  - Katie Sutherland
AU  - Rachel Glover
AU  - Simon Waterhouse
AU  - Emily Turton
AU  - Michelle Horspool
AU  - Rajiv Gandhi
AU  - Deirdre Maguire
AU  - Edward B Jude
AU  - Syed H Ahmed
AU  - Prashanth Vas
AU  - Christian Hariman
AU  - Claire McDougall
AU  - Marion Devers
AU  - Vasileios Tsatlidis
AU  - Martin Johnson
AU  - Andrew S C Rice
AU  - Didier Bouhassira
AU  - David L Bennett
AU  - Dinesh Selvarajah
PY  - 2022
JO  - The Lancet
DO  - 10.1016/s0140-6736(22)01472-6
UR  - https://doi.org/10.1016/s0140-6736(22)01472-6
ER  -

APA

Tesfaye, S., Sloan, G., Petrie, J., White, D., Bradburn, M., Julious, S., Rajbhandari, S., Sharma, S., Rayman, G., Gouni, R., Alam, U., Cooper, C., Loban, A., Sutherland, K., Glover, R., Waterhouse, S., Turton, E., Horspool, M., Gandhi, R., Maguire, D., Jude, E. B., Ahmed, S. H., Vas, P., Hariman, C., McDougall, C., Devers, M., Tsatlidis, V., Johnson, M., Rice, A. S. C., Bouhassira, D., Bennett, D. L., & Selvarajah, D. (2022). Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. The Lancet. https://doi.org/10.1016/s0140-6736(22)01472-6

Source records

crossref · retrieved 2026-09-26T16:47:01.763Z